Recombinant Human FABP3/H-FABP Protein, CF

• Reactivity: Hu
• Format: Carrier-Free

Recombinant Human FABP3/H-FABP Protein, CF Summary

• Details of Functionality: Bioassay data are not available.
• Source: E. coli-derived human FABP3/H-FABP protein
  

  MHHHHHH	GS	Human FABP3/H-FABP (Met1-Ala133) Accession # P05413
  N-terminus		C-terminus

• Accession #: P05413
• N-terminal Sequence: Met
• Protein/Peptide Type: Innovator Recombinant Proteins
• Purity: >95%, by SDS-PAGE under reducing conditions and visualized by silver stain.
• Endotoxin Note: <0.10 EU per 1 μg of the protein by the LAL method.

Applications/Dilutions

• Dilutions:
  • Bioactivity not tested
• Theoretical MW: 16 kDa.
  Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.
• SDS-PAGE: 15 kDa, reducing conditions

Packaging, Storage & Formulations

• Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 3 months, -20 to -70 °C under sterile conditions after reconstitution.
• Buffer: Lyophilized from a 0.2 μm filtered solution in PBS, EDTA and DTT.
• Purity: >95%, by SDS-PAGE under reducing conditions and visualized by silver stain.
• Reconstitution Instructions: Reconstitute at 1 mg/mL in PBS.

Notes

This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.

Alternate Names for Recombinant Human FABP3/H-FABP Protein, CF

• FABP11
• FABP3
• fatty acid binding protein 11
• fatty acid binding protein 3, muscle and heart (mammary-derived growthinhibitor)
• Fatty acid-binding protein 3
• Fatty acid-binding protein 3, muscle
• fatty acid-binding protein, heart
• Heart-type fatty acid-binding protein
• HFABP
• H-FABP
• H-FABPM-FABP
• Mammary-derived growth inhibitor
• MDGI
• Muscle fatty acid-binding protein
• O-FABP

Background

Fatty acid binding protein-3 (FABP3; also named Fatty acid binding protein 11, FABP11, H- or M- (heart or muscle) FABP, Mammary derived growth inhibitor, or MDGI) is a member of a large superfamily of lipid binding proteins that are expressed in a tissue specific manner (1, 9, 10). FABP3 is one of ten cytoplasmic FABPs that are 14-15 kDa in size and range from 126-140 amino acids (aa) in length (1, 2, 3). Although all are highly conserved in their tertiary structure, there is only modest aa identity between any two members. The FABP family members are subdivided based on organ or tissue type it was originally expressed or identified; liver- (L-FABP), intestine- (I-FABP), heart- (H-FABP), adipocyte- (A-FABP), epidermal- (E-FABP), ileal- (IL-FABP), brain- (B-FABP), myelin- (M-FABP) and testis-FABP (T-FABP) (1). Human H-FABP, the product of the FABP3 gene, is a 132 aa cytosolic protein that shows a flattened beta -barrel structure generated by a series of antiparallel beta ‑strands and two alpha ‑helices (4, 5, 7). One molecule of FABP3 is capable of binding one long-chain fatty acid (6, 8, 11). It is suggested that ligands first bind to the outside of the molecule, and this binding subsequently induces a conformational change in the binding protein, resulting in "internalization" of the ligand (7, 11). Human FABP3 is 86%, 89% and 89% aa identical to mouse, rat and canine FABP3, respectively. It also shows 29% and 32% aa identity to human L-FABP and I‑FABP, respectively.

1. Smathers, R & Petersen, D. (2011) Human Genomics 5:170.
2. Storch, J. & Thumser, AE. (2000) Biochim Biophys Acta. 1486:28.
3. Mihajlovic, M. & Lazaridis, T. (2007) Protein Sci. 9:2042.
4. Sweetser, D.A. et al. (1987) J. Biol. Chem. 262:16060.
5. Offner, G. et al. Biochem. J. (1988) 252:191.
6. Glatz JF. et al. (1985) Chem Phys Lipids. 38:115.
7. Bernlohr, DA. et al. (1997) Ann. Rev. of Nut. 17:277.
8. Zanotti G. et al. (1992) J. Biol. Chem. 267:18541.
9. Zimmerman, A.W. & J.H. Veerkamp (2002) Cell. Mol. Life Sci. 59:1096.
10. Haunerland, N.H. and F. Spener (2004) Prog. Lipid Res. 43:328.
11. Majava,V. et al. (2010) PLoS One. 5:e10300.

Bioinformatics

• Uniprot:
  • P05413()